Lunai Bioworks (2Q5) Stock Statistics & Valuation Metrics

Lunai Bioworks has a market cap or net worth of €7.94M. The enterprise value is €16.39M.

Lunai Bioworks has 4,533,890 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lunai Bioworks’s return on equity (ROE) is 8.34 and return on invested capital (ROIC) is 165.94%.

The current PE Ratio of Lunai Bioworks is ―. Lunai Bioworks’s PEG ratio is -0.01.

In the last 12 months, Lunai Bioworks had revenue of 0.00 and earned -178.01M in profits. Earnings per share was -86.24.

In the last 12 months, operating cash flow was -5.26M and capital expenditures -4.00, giving a free cash flow of -5.26M billion.

Lunai Bioworks pays an annual dividend of ―, resulting in a dividend yield of ―

Lunai Bioworks upcoming earnings date is May 15, 2023, TBA (Confirmed).

Lunai Bioworks as a current ratio of 0.04, with Debt / Equity ratio of -14.77%

In the past 12 months, Lunai Bioworks has paid 0.00 in taxes.

Lunai Bioworks EV to EBITDA ratio is -0.27, with an EV/FCF ratio of -6.06.

Lunai Bioworks has €3.16M in cash and marketable securities with €1.41M in debt, giving a net cash position of €1.74M billion.

Gross margin is -360.71%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Lunai Bioworks is ―, which is 11.43% higher than the current price. The consensus rating is ―